EnhKnowTM
Enhance Knowledge LLC
A Technology Brokerage Firm

Loading
 

 

 

 

 

Company Facility Photo
Not Available Yet

 

 Qualprean, Inc
An Adopter Venture of EnhKnow [LLC]

 
Summary Company Profile
State of Formation: State of Delaware
Year of Formation: 2018

Residency (HQ): New Jersey (proposed)
Year of Inception: 2020 (proposed -follow us)
The full fledged operation should start off upon making manifest the Market Participation essential as be continually listed under the Market Participation Planning

Investment Fund: CCECT-PT Capital Investment Fund (proposed)
Investors Participation: Only
By Offering Memorandum
Investment Fund Manager
: N/A
Investment Documents Printing
: Okumaye Publishing Co, Inc

Venture Background:
Website: https://qualprean.enhknow (under construction)
Company Business:
Computational Biological Engineering Science performing  Predictive Analytic Computations of the dynamics of diseases growth in human bodies and response to various treatments.
Company Industry:
Medical Industry with special focus on disease growth dynamics in human body.
Production Technology: Adoption Software:
BioMedic Computations Platform: Diseases Prognostics Analytics
Enabler Technologies: BioSynthesis Reaction-Sequence Computations
  (All technology is licensed through EnhKnow Adoption Brokerage)
Management Contact: Opubo G Benebo,
                                      Executive Chairman,
                                      email: opubob@enhknow.com

 

 

Market Participation Planning
Products: Prognostics Analytics
 March 2020: Virus Infections:
 >> Corona-Virus Science Framework
 Cellular Diseases:
 >> Cancer Biosynthesis & Growth
Production Technology
Jan 1, 2021
The Base Technology enabling minimal working production operations has at this time been consigned to EnhKnow for licensing to this firm (Qualprean, Inc) which should position the firm to enter the Startup Stage. Built on the Viability Analytics production Digital Process Factory with augmenting substitutions, the Base Technology is robust and well-tested; yet it is expected to continue to still be tested and improved while in use.
Company | About Us | News and Events | Contact Us
Privacy Policy | Term of Use | site map

copyright 2008 - , Enhance Knowledge LLC, All rights Reserved